Project description:
Genome-wide tests, nowadays pervasive in medicine, provide an unprecedented opportunity for improving the quality and yield of diagnosis, treatment prescription and research. For example, in rare disease diagnostics, exome sequencing increases resolution of cases dramatically from ~5% five-fold to 25%. They however demand hospitals to seek up-to-date, certified and reliable (bio)informatics solutions to store, manage and analyse such a huge avalanche of data. This is the challenge tackled by the research consortium, supported by Innoviris, which will bring together from February 2014 the expertise of three genetics centers (ULB Erasme, VUB UZ Brussel, UCL DeDuve) and three research groups specialized in database infrastructures and computational intelligence (ULB MLG, ULB IRIDIA et VUB AILab).
The project will take advantage of the alliance of VUB and ULB scientists from the bioinformatics and medical side in the newly created (IB)2 institute, the VUB-ULB Genomics Core, as well as the expertise of the ULB/VUB InSilico Genomics spin-off in representing, storing, curating and managing huge masses of genomic data. The BridgeIRIS project is expected to lead to a number of positive impacts on the Health sector in the Brussels Region.
Profile
You have a PhD in Computational Science, Engineering, Bioinformatics, or equivalent.
We require solid experience with machine learning, data mining,
bioinformatics programming and statistics for bioinformatics.
Experience with the analysis of next-generation sequence data is a plus.
Interest and basic knowledge in genetics is a plus.
You are fluent in English.
The successful applicant will be hosted by the Interuniversity Institute of Bioinformatics in Brussels (ibsquare.be), headed by Prof. Gianluca Bontempi. You will have the ability to interact with people in the Machine Learning Group (mlg.ulb.ac.be).
Starting date: any date after March 1st 2014.
For more information please contact Pr. Gianluca Bontempi, mail: gbonte@ulb.ac.be.
Please send your CV, motivation letter and contact information for three references, publication list with indication of the citation number of each published paper.
